ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
119.1 EUR
-4.72 (-3.81%)
Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 20 industry peers in the Life Sciences Tools & Services industry. ILU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ILU has a correct valuation and a medium growth rate. With these ratings, ILU could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year ILU was profitable.
- In the past year ILU had a positive cash flow from operations.
- In multiple years ILU reported negative net income over the last 5 years.
- ILU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of ILU (11.38%) is better than 95.00% of its industry peers.
- Looking at the Return On Equity, with a value of 29.53%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 14.61%, ILU belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of ILU (16.39%) is better than 90.00% of its industry peers.
- ILU has a better Operating Margin (20.41%) than 90.00% of its industry peers.
- ILU's Operating Margin has declined in the last couple of years.
- ILU has a better Gross Margin (66.74%) than 100.00% of its industry peers.
- In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILU is creating some value.
- Compared to 1 year ago, ILU has about the same amount of shares outstanding.
- ILU has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ILU has a worse debt to assets ratio.
2.2 Solvency
- ILU has an Altman-Z score of 4.50. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
- ILU has a Altman-Z score of 4.50. This is amongst the best in the industry. ILU outperforms 85.00% of its industry peers.
- ILU has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.99, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
- ILU's Debt to Equity ratio of 0.42 is fine compared to the rest of the industry. ILU outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.5 |
ROIC/WACC1.35
WACC10.81%
2.3 Liquidity
- ILU has a Current Ratio of 1.43. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of ILU (1.43) is comparable to the rest of the industry.
- ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
- ILU has a Quick ratio of 1.12. This is in the better half of the industry: ILU outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 152.02% over the past year.
- Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
- ILU shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
- The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
- Based on estimates for the next years, ILU will show a very strong growth in Earnings Per Share. The EPS will grow by 24.95% on average per year.
- Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 3.99% on average per year.
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue Next Year-0.88%
Revenue Next 2Y0.73%
Revenue Next 3Y2.34%
Revenue Next 5Y3.99%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- ILU is valuated quite expensively with a Price/Earnings ratio of 31.76.
- Based on the Price/Earnings ratio, ILU is valued a bit more expensive than 60.00% of the companies in the same industry.
- ILU's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.38.
- A Price/Forward Earnings ratio of 27.03 indicates a quite expensive valuation of ILU.
- ILU's Price/Forward Earnings ratio is in line with the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. ILU is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.76 | ||
| Fwd PE | 27.03 |
4.2 Price Multiples
- ILU's Enterprise Value to EBITDA ratio is in line with the industry average.
- 75.00% of the companies in the same industry are more expensive than ILU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.17 | ||
| EV/EBITDA | 18.83 |
4.3 Compensation for Growth
- ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ILU has a very decent profitability rating, which may justify a higher PE ratio.
- ILU's earnings are expected to grow with 34.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y44.64%
EPS Next 3Y34.05%
5. Dividend
5.1 Amount
- ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:ILU (1/19/2026, 7:00:00 PM)
119.1
-4.72 (-3.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap18.20B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts73.33
Price Target111.36 (-6.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)5.42%
PT rev (3m)13.87%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.76 | ||
| Fwd PE | 27.03 | ||
| P/S | 4.94 | ||
| P/FCF | 21.17 | ||
| P/OCF | 18.87 | ||
| P/B | 8.89 | ||
| P/tB | 20.29 | ||
| EV/EBITDA | 18.83 |
EPS(TTM)3.75
EY3.15%
EPS(NY)4.41
Fwd EY3.7%
FCF(TTM)5.63
FCFY4.72%
OCF(TTM)6.31
OCFY5.3%
SpS24.13
BVpS13.4
TBVpS5.87
PEG (NY)0.33
PEG (5Y)N/A
Graham Number33.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.5 |
F-Score7
WACC10.81%
ROIC/WACC1.35
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.88%
Revenue Next 2Y0.73%
Revenue Next 3Y2.34%
Revenue Next 5Y3.99%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year36.79%
EBIT Next 3Y17.14%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status for ILU stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for ILU stock?
The financial health rating of ILLUMINA INC (ILU.DE) is 7 / 10.